By Josh Beckerman

 

Johnson & Johnson said it remains committed to supplying 200 million doses of its Covid-19 vaccine to the European Union, Norway and Iceland.

Earlier Tuesday, the European Medicines Agency called for a warning about very rare blood clots but said the benefits of the vaccine outweigh the risks.

J&J said it will update the Summary of Product Characteristics and Package Leaflet. "Healthcare professionals will be alerted to the signs and symptoms of thromboembolism with thrombocytopenia, as well as the appropriate course of treatment," the company said.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

April 20, 2021 12:36 ET (16:36 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024 Click aqui para mais gráficos Johnson and Johnson.
Johnson and Johnson (NYSE:JNJ)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024 Click aqui para mais gráficos Johnson and Johnson.